Keywords: grupo, vita, begins, ph, vanh36, study, spain

Grupo Vita begins Ph I VANH36 study

Article | 27 September 2001

Print This

l Spain's Grupo Vita has initiated a Phase I safety, tolerability andpharmacokinetic clinical trial of its pain treatment VANH36, which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in